Explore comprehensive CDMO services offered by Mayne Pharma, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Mayne Pharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Australia
Description: Mayne Pharma is an ASX-listed specialty pharmaceutical company known for developing and commercializing branded and generic drugs, with strong expertise in advanced oral drug delivery systems (like modified-release pellets) and complex formulations, also offering Contract Development & Manufacturing (CDMO) services globally, operating from Australia and the USA. They focus on improving patient access to vital medications through innovation, serving markets in North America, Australia, Asia, and Europe with a portfolio of over 90 products and a commitment to quality and ethical practices.
